Back to resultsEvaluation of Neutrophil/Lymphocyte Ratio ,Platelet/Lymphocyte Ratio and CRP as Markers of Severity of Pre-eclampsia
Primary Purpose
Pre-Eclampsia
Status
Unknown status
Phase
Not Applicable
Locations
Egypt
Study Type
Interventional
Intervention
Neutrophil/lymphocyte ratio, Platelet /lymphocyte ratio and CRP
Sponsored by
About this trial
This is an interventional diagnostic trial for Pre-Eclampsia
Eligibility Criteria
Inclusion Criteria:
- PREECLAMPSIA from 25_45years
Exclusion Criteria:
- chronic diseases Primary hypertension
Sites / Locations
- ShazaRecruiting
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm Type
Other
Other
Other
Arm Label
Neutrophil/lymphocyte ratio
Platelet/lymphocyte ratio
CRP
Arm Description
Outcomes
Primary Outcome Measures
PREECLAMPSIA
Secondary Outcome Measures
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT03630276
Brief Title
Evaluation of Neutrophil/Lymphocyte Ratio ,Platelet/Lymphocyte Ratio and CRP as Markers of Severity of Pre-eclampsia
Official Title
Evaluation of Neutrophil/Lymphocyte Ratio, Platelet /Lymphocyte Ratio and CRP as Markers of Severity of Pre-eclampsia
Study Type
Interventional
2. Study Status
Record Verification Date
August 2018
Overall Recruitment Status
Unknown status
Study Start Date
August 1, 2018 (Actual)
Primary Completion Date
August 10, 2018 (Actual)
Study Completion Date
August 10, 2018 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Ain Shams University
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
5. Study Description
Brief Summary
Evaluation of neutrophil/lymphocyte ratio, Platelet /lymphocyte ratio and CRP as markers of severity of Pre-eclampsia
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Pre-Eclampsia
7. Study Design
Primary Purpose
Diagnostic
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
Care Provider
Allocation
Randomized
Enrollment
111 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Neutrophil/lymphocyte ratio
Arm Type
Other
Arm Title
Platelet/lymphocyte ratio
Arm Type
Other
Arm Title
CRP
Arm Type
Other
Intervention Type
Diagnostic Test
Intervention Name(s)
Neutrophil/lymphocyte ratio, Platelet /lymphocyte ratio and CRP
Intervention Description
Lab
Primary Outcome Measure Information:
Title
PREECLAMPSIA
Time Frame
6months
10. Eligibility
Sex
Female
Minimum Age & Unit of Time
25 Years
Maximum Age & Unit of Time
45 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
- PREECLAMPSIA from 25_45years
Exclusion Criteria:
chronic diseases Primary hypertension
Facility Information:
Facility Name
Shaza
City
Alexandria
State/Province
Alex
ZIP/Postal Code
12345
Country
Egypt
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Shaza Mohamed Elreweny, Master
Phone
01090700297
Email
Dr_shaza_elreweny@yahoo.com
12. IPD Sharing Statement
Learn more about this trial
Evaluation of Neutrophil/Lymphocyte Ratio ,Platelet/Lymphocyte Ratio and CRP as Markers of Severity of Pre-eclampsia
We'll reach out to this number within 24 hrs